Neola Medical has strengthened its management team, adding David Folkesson as the new CFO. He joins at an important stage for the company, which is currently preparing for clinical validation of Neola®. BioStock has contacted David to find out more about his background and how he sees the journey that currently lies ahead.
Read the entire article by BioStock here: BioStock article – New CFO at Neola Medical